Madoka Toyoda

Madoka Toyoda

Auto-generated profile, based on publicly available information

Madoka Toyoda

Department of Surgery, Yokohama City University, Graduate School of Medicine, Kanagawa, Japan; Department of Thoracic Surgery, Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Endocrinology, Diabetes & Metabolism Case Reports
Verified
Journal Article
Open access
PDF file
MTMadoka Toyoda
Madoka Toyoda
NSNobuyasu Suganuma
Nobuyasu Suganuma
ATAkari Takahashi
Akari Takahashi
TMTaku Masuda
Taku Masuda
MGMasami Goda
Masami Goda
MMMunetaka Masuda
Munetaka Masuda
Summary: Emergencies due to malignancies usually have a severe clinical course and require urgent treatment. These scenarios are dubbed ‘oncologic emergencies’. Parathyroid tumours often cause hypercalcaemia but not oncologic emergencies. We present a case of parathyroid carcinoma with severe hypercalcaemia and pancreatitis, resolved by surgical resection of the tumour assisted by extracorporeal membrane oxygenation (ECMO). A 66-year-old woman presented to our hospital because of haematuria. Laboratory findings were as follows: white blood cell count: 30 000, C-reactive protein: 17.7, calcium: 21.9, creatine kinase: 316, creatine kinase-myoglobin binding: 20, troponin I: 1415.8, amylase: 1046, lipase: 499, blood urea nitrogen: 57, and creatinine: 2.42. ECG was unremarkable. CT revealed a 4-cm low-density irregular tumour in the left lobe of the thyroid gland and severe pancreatitis. We diagnosed hypercalcaemia and pancreatitis due to parathyroid carcinoma. Volume expansion with isotonic saline was started immediately. Calcitonin, followed by denosumab, calcimimetic agents, and continuous hemodiafiltration were administered. The patient’s general condition worsened due to uncontrolled hypercalcaemia. Urgent tumour resection was planned, assisted with ECMO for cardiopulmonary support and surgical field venous pressure reduction. Tumour histology was suggestive of parathyroid carcinoma. Hypercalcaemia and the patient’s general condition improved gradually postoperatively. Hypercalcaemia is one of the oncologic emergency symptoms, commonly occurring because of lytic bone metastasis. However, reports about parathyroid carcinoma-causing life-threatening hypercalcaemia and pancreatitis are scarce; the fatality of this condition is estimated to be 30–70%. We report a case of survival of hypercalcaemia of malignancy. Learning points: Parathyroid carcinoma is relatively rare and sometimes causes emergent conditions such as hypercalcaemia and severe pancreatitis. General therapy for hypercalcaemia including aggressive saline dehydration, administration of furosemide, calcitonin, zoledronic acid, and evocalcet, and dialysis is sometimes ineffective for parathyroid carcinoma. Therefore, careful planning of therapy in case of exacerbation is important. During an emergency, rapid surgical treatment despite high calcium level is the best potential therapeutic strategy.

29 May 2026 in Cancer Treatment and Research Communications
Verified
Journal Article
Open access
MTMadoka Toyoda
Madoka Toyoda
TWTetsukan Woo
Tetsukan Woo
TSTomoe Sawazumi
Tomoe Sawazumi
MMMai Matsumura
Mai Matsumura
HNHitoshi Niino
Hitoshi Niino
ASAya Saito
Aya Saito
The objective of this study was to clarify the clinicopathological features and prognostic factors of pulmonary pleomorphic carcinoma (PPC) in a multicenter setting. We conducted a retrospective study of PPC patients across four hospitals between 2000 and 2021. Among 4425 resected cases of non-small cell lung cancer (NSCLC), 84 cases (1.9%) were diagnosed as PPC. Clinical records and pathological specimens were reviewed. PPC patients had significantly poorer recurrence-free survival (RFS) and overall survival (OS) than those with other NSCLC subtypes (5-year RFS: 33.0% vs. 59.7%, P < 0.001; 5-year OS: 45.1% vs. 69.7%, P < 0.001). Multivariate analysis identified two independent adverse prognostic factors for RFS: sarcomatoid component ≥50% and tumor necrosis ≥30%. Based on these two factors, PPC patients were stratified into three prognostic risk groups: high-risk (both factors), intermediate-risk (one), and low-risk (neither). The high-risk group demonstrated significantly worse RFS and OS compared with the low-risk group. Furthermore, PD-L1 expression was significantly higher in the high-risk group (median PD-L1 expression: 20% in low-risk, 70% in intermediate-risk, 80% in high-risk; P = 0.026). This study identified sarcomatoid component ≥50% and necrosis ≥30% as significant adverse prognostic indicators for RFS in PPC. Stratification into three prognostic risk groups based on these two features may aid in risk assessment and treatment planning. Notably, the high-risk group showed markedly elevated PD-L1 expression, suggesting its potential as a predictor of response to immune checkpoint inhibitors. Further large-scale prospective studies are warranted to validate these findings and improve therapeutic strategies for PPC. This study analyzed 84 cases of pulmonary pleomorphic carcinoma (PPC). Multivariate analysis identified a sarcomatoid component ≥50% and tumor necrosis ≥30% as independent adverse prognostic factors for recurrence-free survival (RFS). Based on these two factors, PPC patients were stratified into three prognostic risk groups. Notably, the high-risk group exhibited significantly higher PD-L1 expression than the low-risk group, suggesting its potential as a predictor of response to immune checkpoint inhibitors.